On Infrastructure, California Goes Back to Basics

Governing | July 18, 2017

On Infrastructure, California Goes Back to Basics
For the first time since 1989, California lawmakers this year passed a gas tax hike. The increase  by 12 cents a gallon on gasoline and 20 cents a gallon on diesel  will pay for a decade-long building program that will cost $54 billion. California is one of many states this year to raise its fuel taxes, but the state's sheer size makes the new transportation funding law significant. The Trump administration, by comparison, has broadly outlined a $1 trillion investment in infrastructure over a decade  only $200 million of which would come from the federal government. In other words, over the next decade, California will spend a quarter of what the federal government would spend on the entire country under Trump’s plan.

Spotlight

Any generic drug modeled after a single, brand name drug must perform approximately the same in the body as the brand name drug. There will always be a slight, but not medically important, level of natural variability just as there is for one batch of brand name drug compared to the next batch of brand name product.

Related News

GOVERNMENT BUSINESS

Acalvio ShadowPlex Achieves “FedRAMP Ready” Designation

Acalvio Technologies | October 27, 2021

Acalvio Technologies, the leader in Autonomous Deception, today announced that it has been approved as “FedRAMP Ready” for Agency Authorization. Acalvio achieved FedRAMP Ready status at the Moderate Impact Level for its ShadowPlex platform on Amazon Web Services (AWS). ShadowPlex is now listed in the FedRAMP Marketplace. Acalvio’s award-winning Autonomous Deception™ platform, ShadowPlex, enables organizations to detect, investigate and respond to malicious activity inside the perimeter. Acalvio’s solutions are anchored on innovations in Distributed Deception, and Artificial Intelligence (AI), enabling security teams to cut through the cycle of endless alerts and accelerate threat detection by focusing on high fidelity detections, all while minimizing the incidence of potential false positives. ShadowPlex patented architecture allows distributed and autonomous deployment of effective deception, with minimal IT overhead across On-premises and Cloud workloads and remote user machines. A comprehensive and extensible deception palette covers both IT and OT environments and reduces attacker dwell time by detecting malicious activity with precision and speed. Solutions authorized at the FedRAMP Moderate Impact Level protect the government’s sensitive unclassified data in cloud environments, including data where the loss of confidentiality, integrity, and availability would result in serious adverse effects on a Federal agency’s operations, assets, or individuals. “Acalvio ShadowPlex provides an effective and differentiated solution to detect and respond to advanced threats, even zero-day attacks. U.S. government departments and agencies need active defense solutions in place today to be ready for the increasing sophistication of cyberattacks facing our Nation. By achieving the FedRAMP Ready designation, Acalvio has demonstrated they are a valued partner for entities who wish to defend against cyber threats today.” Ram Varadarajan, co-Founder & CEO at Acalvio Technologies The FedRAMP Ready status adds to the SOC 2 and NIST 800-171 certifications previously achieved by Acalvio Technologies. About FedRAMP The Federal Risk and Authorization Management Program (FedRAMP) is a government-wide program that provides a standardized approach to security assessment, authorization, and continuous monitoring for cloud products and services. Using a “do once, use many times” framework, the program ensures information systems/services used government-wide have adequate information security; eliminates duplication of effort and reduces risk management costs; and enables rapid and cost-effective procurement of information systems/services for federal agencies. About Acalvio Technologies Acalvio invented breakthrough Deception Technology based on 25+ issued patents and integrated it with advanced AI to provide industry leading autonomous deception solution that is effective, easy to use, and enterprise scale. Acalvio ShadowPlex reduces attacker dwell time by early detection of advanced threats and increases SOC efficiency by sophisticated investigation and active threat-hunting capabilities. Extensive partner integrations allow ShadowPlex to leverage customer’s security ecosystem for rapid and comprehensive threat containment. The Silicon Valley based company is led by an experienced team with a track record of innovation and market leadership and backed by marquee investors.

Read More

QOMPLX Releases The CMMC Pre-Assessment Solution to Prepare Defense Contractors to Pass Their CMMC Audit

QOMPLX | September 10, 2020

QOMPLX™, an intelligent decision platform provider, today announced the release of the CMMC Pre-Assessment, a solution to help prepare defense contractors to pass their Cybersecurity Maturity Model Certification (CMMC) audit. The U.S. Department of Defense (DoD) created CMMC to enhance the cybersecurity posture of the companies that make up the Defense Industrial Base (DIB). As part of this upcoming prerequisite, all 300,000+ DIB companies will be required to meet specific maturity levels to be awarded a contract from the DOD. Previously, companies could self-certify with the appropriate Defense Federal Acquisition Regulations (DFARS) and other regulations such as NIST 800-171, but CMMC now requires third-party auditors to validate if contractors are compliant with the required cybersecurity practices and procedures.

Read More

Verndari, Inc. Announces a Federal Government Award to Support Development of Verndari’s VaxiPatch™ Alternative Vaccine Technology

Verndari, Inc. | August 27, 2020

Verndari, Inc., a biopharmaceutical company transforming vaccines with next generation science and delivery technology, announced today a federal government award to support development of Verndari’s VaxiPatch™ alternative vaccine technology. The award is funded through DRIVe the (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority (BARDA), under the Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services.

Read More

Spotlight

Any generic drug modeled after a single, brand name drug must perform approximately the same in the body as the brand name drug. There will always be a slight, but not medically important, level of natural variability just as there is for one batch of brand name drug compared to the next batch of brand name product.